Scientific Terms
Renewed Focus on Rapid SARS-CoV-2 Testing Has Dx Stakeholders Concerned About Meeting Demand
Premium
After the federal government's investments into rapid and at-home testing, there are concerns whether manufacturers can meet demand.
Natera Builds Data Backing Serial ctDNA Changes to Aid CRC Patient Management, Treatment Decisions
Premium
The company believes its findings are the first to show that quantifying ctDNA changes can stratify high-risk colorectal cancer patients into better and worse prognostic groups.
RADx Issues $77.7M in New Contracts for SARS-CoV-2 Rapid Diagnostic Tests
The awards support the development, validation, scale-up, and manufacturing of the tests with the goal of bringing them to market as early as this year.
Swiss Blood Collection Device Company Closes $6.4M in Series A Financing
Loop Medical said it is developing a minimally invasive blood collection device to collect sample volumes large enough that they are compatible with high-throughput blood analyzers.
EU IVDR Implementation Woes Could Severely Limit Cancer Companion Test, Precision Therapy Access
Premium
The EC has stuck with its timeline to implement the new regulations in eight months, raising concerns for cancer patients' ability to receive biomarker testing and treatments.